• UCLA Health
  • myUCLAhealth
  • School of Medicine
CASIT

Center for Advanced Surgical & Interventional Technology (CASIT)

CASIT
  • UCLA Surgery
  • About Us
    • What is CASIT
    • History
    • CASIT Governance and Collaboration
    • Booking Information & Directions
    • Contact Us
  • Education
    • Course Offerings
    • FLS and FES Testing
    • Surgical Education Technologies
    • CASIT Medical Education and Simulation Fellowship
    • Robotic Pancreas Surgery Program
    • Past Conferences
  • Research Innovation
    • Focal Laser Ablation for Prostate Cancer Treatment
    • Ultrasound-MRI Fusion for Targeted Diagnosis of Prostate Cancer
    • Previous Projects
  • Join & Contribute
    • CASIT Giving
  • Meet Our Team
  • Quick Links
    • CASIT Calendar
    • Newsletter
    • Contact Us
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

Center for Advanced Surgical & Interventional Technology (CASIT)

Research Innovation

Research Innovation

Research Innovation

  • Focal Laser Ablation for Prostate Cancer Treatment
  • Ultrasound-MRI Fusion for Targeted Diagnosis of Prostate Cancer
  • Previous Projects
    • Low-Intensity Focused Ultrasound for Transcranial Neuromodulation
    • Vibroacoustography for Head and Neck Cancer Margin Detection
    • Tactile Feedback for Prostheses and Sensory Neuropathy
    • Reflective Terahertz Medical Imaging Systems
    • Laser-generated Shockwaves for Treatment of Infected Wounds
    • Ultrasound-Guided Procedural Training
    • Clinical Research
    • Motion Scaling
    • Surgical Simulations Involving Elastic Cardiac Geometries
    • Rapid Transition Polymer for Temporary Vascular Occlusion During Segmental Liver Resection
    • Developing and Testing Thin Film Nitinol Low-Profile Devices for use in Vascular Repair
    • Flexible 3D ultrasound technology for diagnosis of injuries and intra-operative guidance
    • Novel Telepresence Application Using Robotic Wireless System
    • MEMS Sensors for In-vivo Patient Monitoring
    • Haptic-Guided Telementoring Systems
  • Focal Laser Ablation for Prostate Cancer Treatment
  • Ultrasound-MRI Fusion for Targeted Diagnosis of Prostate Cancer
  • Previous Projects
  1. Home
  2. CASIT
  3. Research Innovation
  4. Ultrasound-MRI Fusion for Targeted Diagnosis of Prostate Cancer

Ultrasound-MRI Fusion for Targeted Diagnosis of Prostate Cancer

Share this

Introduction

Prostate cancer is the most prevalent cancer in men with ~175,000 confirmed cases per year leading to ~30,000 deaths. Widespread adoption of PSA testing has led to a trend of overdiagnosis with many clinically insignificant lesions considered for treatment. More recently, the development of advanced MRI techniques has facilitated localization of cancerous regions within the prostate (Figure 1), however, accurate biopsies are required to assess the clinical significance of the MRI visible lesion. In addition, there is evidence that MRI underestimates the extent of the cancerous tissue, thus, precision biopsies may improve our ability to quantify the true size of the cancerous lesion. Ultimately our goal is to combine the information provided by both MRI and biopsy to better inform treatment selection.

Ultrasound-MRI FusionFigure 1: MRI showing regions of interest (ROI) suspicious for prostate cancer

Ultrasound-MRI Fusion Biopsy with the Artemis Device

Conventional biopsies are performed in a systematic manner in which tissue samples are acquired throughout the prostate. Consequently, cancerous lesions are frequently missed due to the inability to accurately target the biopsy to regions that are suspicious for cancer. At UCLA we have collaborated with Eigen Corp. in the development of the Artemis device which is capable of targeted biopsy. The Artemis device consists of 3 main parts: a tracking arm, a monitor, and a work station (Figure 2 left). In brief, a conventional ultrasound unit is used to image the prostate trans-rectally. The tracking arm attaches to the ultrasound probe, allowing a capture of the scanned prostate by the processor. From the ultrasound feed, a 3D reconstruction of the prostate is created on the monitor in a near-realtime manner (Figure 2 right). MRI identified regions of interest are then fused with the real-time ultrasound which enables accurate targeting of biopsy needles to the relevant tissue. In addition, systematic biopsy may be taken to assess other regions for cancer.

Ultrasound-MRI Fusion

Figure 2: Left – The Artemis device. Right – The MRI identified region of interest (Green) is overlaid on a 3D model of the prostate acquired using real-time ultrasound. The Artemis tracking arm allows the physician to guide the biopsy needle to the desired location. In this cases a concentration of biopsy cores are acquired from the region of interest previously found with MRI.

The Artemis device is now routinely used at UCLA for diagnosing prostate cancer as summarized in the video below.

Current Research

  • Cancer Staging – To date we have performed over 4,000 targeted biopsies and by analysis of this data we hope to improve cancer staging and treatment selection.
  • Focal Therapy Eligibility - Focal therapy has emerged as method of treating the cancerous lesion while sparing surrounding healthy tissue. It offers an effective treatment for prostate cancer with substantially fewer side-effects than conventional treatments such as radical prostatectomy and radiation therapy. By combing MRI and targeted biopsy data we seek to identify patients that may be treated with focal therapy.
  • Treatment Planning – Hight Intensity Focused Ultrasound, Cryotherapy and Focal Laser Ablation are all promising modalities for focal treatment of prostate cancer. We are developing treatment planning techniques for all of these modalities with the aim of improving treatment outcomes and better informing the appropriate treatment modality on a case by case basis. To do so it is essential to quantify the true extent of the cancer which is not possible with MRI alone (Figure 3).
Ultrasound-MRI FusionFigure 3: MRI underestimation of true tumor size.

Profile Photo
Leonard Marks, MD

Professor, deKernion Endowed Chair in Urology
Profile Photo
Rory Geoghegan, PhD

Project Scientist
Profile Photo
Shyam Natarajan

 
Profile Photo
Alan Priester, PhD

Assistant Project Scientist, Department of Urology
Profile Photo
Jake Pensa, MS

Graduate Student Researcher

Selected Publications:

Zhang, Z., Wu, H. H., Priester, A., Magyar, C., Afshari Mirak, S., Shakeri, S., ... & Reiter, R. E. (2020). Prostate microstructure in prostate cancer using 3-T MRI with diffusion-relaxation correlation spectrum imaging: validation with whole-mount digital histopathology. Radiology, 192330.

Nassiri, N., Margolis, D. J., Natarajan, S., Sharma, D. S., Huang, J., Dorey, F. J., & Marks, L. S. (2017). Targeted biopsy to detect Gleason score upgrading during active surveillance for men with low versus intermediate risk prostate cancer. The Journal of urology, 197(3), 632-639.

Priester, A., Natarajan, S., Khoshnoodi, P., Margolis, D. J., Raman, S. S., Reiter, R. E., ... & Marks, L. S. (2017). Magnetic resonance imaging underestimation of prostate cancer geometry: use of patient specific molds to correlate images with whole mount pathology. The Journal of urology, 197(2), 320-326.

Filson, C. P., Natarajan, S., Margolis, D. J., Huang, J., Lieu, P., Dorey, F. J., ... & Marks, L. S. (2016). Prostate cancer detection with magnetic resonance‐ultrasound fusion biopsy: the role of systematic and targeted biopsies. Cancer, 122(6), 884-892.

Priester, A., Natarajan, S., Le, J. D., Garritano, J., Radosavcev, B., Grundfest, W., ... & Huang, J. (2014). A system for evaluating magnetic resonance imaging of prostate cancer using patient-specific 3D printed molds. American journal of clinical and experimental urology, 2(2), 127.

Sonn, G. A., Chang, E., Natarajan, S., Margolis, D. J., Macairan, M., Lieu, P., ... & Marks, L. S. (2014). Value of targeted prostate biopsy using magnetic resonance–ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. European urology, 65(4), 809-815.

Sonn, G. A., Natarajan, S., Margolis, D. J., MacAiran, M., Lieu, P., Huang, J., ... & Marks, L. S. (2013). Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device. The Journal of urology, 189(1), 86-92.

Marks, L., Young, S., & Natarajan, S. (2013). MRI–ultrasound fusion for guidance of targeted prostate biopsy. Current opinion in urology, 23(1), 43.

Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth

Learn more about myUCLAhealth